• Home
  • /
  • Products
  • /
  • Epinephrine — 30MG, Concentrate for solution for injection, carton of 1 × 30 mL vial

Epinephrine — 30MG, Concentrate for solution for injection, carton of 1 × 30 mL vial

NDC/Item Number: 63323069830
Manufacturer:
FRESENIUS KABI
Form
MDV
Unit size
30ML
Strength
30MG

Details

Details

Epinephrine — 30MG, Concentrate for solution for injection, carton of 1 × 30 mL vial

Epinephrine is a concentrate for solution for injection for intramuscular; intravenous; subcutaneous use. Epinephrine is a non-selective alpha and beta adrenergic agonist indicated: • For emergency treatment of allergic reactions (Type 1), including anaphylaxis, in adults and pediatric patients. ( 1.1 ) • To increase mean arterial blood pressure in adult patients with hypotension associated with septic shock. ( 1.2 ) 1.1 Anaphylaxis Epinephrine Injection is indicated for emergency treatment of type I allergic reactions, including anaphylaxis, in adults and pediatric patients. 1.2 Hypotension associated with Septic Shock Epinephrine Injection is indicated to increase mean arterial blood pressure in adult patients with hypotension associated with septic shock.

  • Active ingredient or product type: EPINEPHRINE
  • Strength/concentration: 30MG
  • Dosage form and route: Concentrate for solution for injection, Intramuscular; Intravenous; Subcutaneous
  • Exact package presentation: carton of 1 × 30 mL vial
  • NDC/item number: 63323-698-30
  • Manufacturer: FRESENIUS KABI
  • Storage/handling: Protect from light until ready to use. refrigerate. Protect from freezing.
  • Status: Rx only

Important safety information: • Do not inject into buttocks, digits, hands, or feet. ( 5.1 ) • Avoid extravasation into tissues, which can cause local necrosis. ( 5.3 ) • Monitor patient for acute severe hypertension. ( 5.4 ) • Potential for pulmonary edema, which may be fatal. ( 5.5 ) • May constrict renal blood vessels and decrease urine formation. ( 5.6 ) • May induce potentially serious cardiac arrhythmias or aggravate angina • pectoris, particularly in patients with underlying heart disease. ( 5.7 ) • Presence of sulfit

Refer to the current product labeling for complete indications, preparation or administration instructions, contraindications, warnings, precautions, and storage requirements.